• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 TNF-α 诱导狼疮的多种表现形式:病例系列和文献复习。

Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.

机构信息

Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel.

Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel.

出版信息

Clin Rheumatol. 2018 Feb;37(2):563-568. doi: 10.1007/s10067-017-3884-2. Epub 2017 Oct 23.

DOI:10.1007/s10067-017-3884-2
PMID:29063464
Abstract

The induction of autoantibodies is common following therapy with anti-TNF-α agents. However, anti-TNF-α-induced lupus (ATIL) is rare. We assessed the clinical characteristics of three patients with inflammatory bowel disease (IBD) who were treated with infliximab and developed distinct subsets of ATIL. Also, we searched for similar cases in the published literature. We describe three patients with ATIL. The first patient had a classical drug-induced lupus (DIL) presented by thrombocytopenia that resolved after infliximab discontinuation. The second case experienced symmetric polyarthritis of 14 joints in rheumatoid arthritis (RA)-like distribution accompanied by lymphopenia. The third one had a severe serositis including ascites and pleural and pericardial effusions along with pancytopenia. In this patient, ATIL coexisted with anti-TNF-α-induced hepatitis. The second and third patients met the American College of Rheumatology classification criteria for SLE. Nevertheless, all three cases exhibited ANA and anti-dsDNA positivity, and only the second patient had anticardiolipin (aCL IgG) and anti-histone antibodies. The coexistence of both lupus-like syndrome and hepatitis following anti-TNF-α therapy in the same patient is very rare, and to the best of our knowledge, only four such case reports are mentioned in literature. Patients with mild ATIL may tolerate another anti-TNF-α agent without recurrence of the disease. Rheumatologists should be aware of the distinct clinical presentations of ATIL and its coexistence with other rare anti-TNF-alpha complications such as hepatitis.

摘要

抗 TNF-α 药物治疗后常可诱导自身抗体产生。然而,抗 TNF-α 诱导的狼疮(ATIL)较为罕见。我们评估了三例接受英夫利昔单抗治疗的炎症性肠病(IBD)患者的临床特征,他们均发生了不同类型的 ATIL。此外,我们还在已发表的文献中搜索了类似病例。我们描述了三例 ATIL 患者。第一例患者表现为经典的药物诱导性狼疮(DIL),伴有血小板减少,停药后缓解。第二例患者出现类似类风湿关节炎(RA)的 14 个关节对称性多关节炎,伴有淋巴细胞减少。第三例患者有严重的浆膜炎,包括腹水、胸腔和心包积液,同时伴有全血细胞减少。在该患者中,ATIL 与抗 TNF-α 诱导的肝炎并存。第二例和第三例患者符合美国风湿病学会(ACR)系统性红斑狼疮(SLE)分类标准。然而,所有三例患者均表现为 ANA 和抗 dsDNA 阳性,仅第二例患者有抗心磷脂(aCL IgG)和抗组蛋白抗体。抗 TNF-α 治疗后同一患者同时出现狼疮样综合征和肝炎非常罕见,据我们所知,文献中仅报道了四例此类病例。轻度 ATIL 患者可能耐受另一种抗 TNF-α 药物而不复发疾病。风湿病学家应注意到 ATIL 的独特临床表现及其与其他罕见抗 TNF-α 并发症(如肝炎)的共存。

相似文献

1
Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.抗 TNF-α 诱导狼疮的多种表现形式:病例系列和文献复习。
Clin Rheumatol. 2018 Feb;37(2):563-568. doi: 10.1007/s10067-017-3884-2. Epub 2017 Oct 23.
2
Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.类风湿关节炎和强直性脊柱炎患者接受英夫利昔单抗和依那西普治疗后4个月随访时的抗核抗体及狼疮样表现
Curr Rheumatol Rev. 2020;16(1):61-66. doi: 10.2174/1573397115666190506152729.
3
TNF-alpha antagonist induced lupus on three different agents.肿瘤坏死因子-α拮抗剂在三种不同药物上诱发狼疮。
Postgrad Med. 2017 Mar;129(2):304-306. doi: 10.1080/00325481.2017.1249266. Epub 2016 Oct 28.
4
Anti-TNF-induced lupus.抗TNF诱导的狼疮。
Rheumatology (Oxford). 2009 Jul;48(7):716-20. doi: 10.1093/rheumatology/kep080. Epub 2009 May 4.
5
TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.肿瘤坏死因子-α拮抗剂诱导的狼疮样综合征:报告及文献复习,并探讨了使用替代肿瘤坏死因子-α拮抗剂治疗的影响。
Int J Dermatol. 2011 May;50(5):619-25. doi: 10.1111/j.1365-4632.2011.04871.x.
6
TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.一名接受阿达木单抗治疗类风湿关节炎的患者发生了肿瘤坏死因子抑制剂诱导的狼疮。
Dermatol Online J. 2014 Dec 13;21(2):13030/qt18r2916d.
7
A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?英夫利昔单抗诱导的强直性脊柱炎患者狼疮:转换为另一种抗 TNF-α 药物安全吗?
Clin Rheumatol. 2013 Dec;32(12):1819-22. doi: 10.1007/s10067-013-2361-9. Epub 2013 Aug 17.
8
Retention rates of adalimumab, etanercept and infliximab as first-line biotherapy agent for rheumatoid arthritis patients in daily practice - Auvergne experience.阿达木单抗、依那西普和英夫利昔单抗作为类风湿关节炎患者一线生物治疗药物在日常临床实践中的留存率——奥弗涅地区的经验
Int J Rheum Dis. 2018 Nov;21(11):1924-1932. doi: 10.1111/1756-185X.13156. Epub 2017 Sep 13.
9
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.一线抗TNF药物在成人和青少年发病的炎症性关节炎患者中的真实世界10年保留率:异同点
Clin Rheumatol. 2017 Aug;36(8):1747-1755. doi: 10.1007/s10067-017-3712-8. Epub 2017 Jun 8.
10
Anti-TNF-α-induced lupus syndrome : Two case reports and review of current literature.抗 TNF-α 诱导的狼疮综合征:两例病例报告并复习当前文献。
Z Rheumatol. 2021 Jun;80(5):481-486. doi: 10.1007/s00393-021-00983-8. Epub 2021 Mar 11.

引用本文的文献

1
A Therapeutic Tightrope: Managing Coexisting Crohn Disease and Systemic Lupus Erythematosus With Risankizumab.治疗的钢丝:使用瑞莎珠单抗治疗克罗恩病和系统性红斑狼疮并存的情况
ACG Case Rep J. 2025 Sep 8;12(9):e01830. doi: 10.14309/crj.0000000000001830. eCollection 2025 Sep.
2
Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy.理性应用抗风湿药物治疗类风湿关节炎:意大利基于药品说明书的策略。
Front Immunol. 2024 Jun 24;15:1398314. doi: 10.3389/fimmu.2024.1398314. eCollection 2024.
3
Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature.

本文引用的文献

1
Rapidly progressive lupus nephritis associated with golimumab in a patient with systemic lupus erythematosus and rheumatoid arthritis.
Lupus. 2017 Apr;26(4):447-448. doi: 10.1177/0961203316662724. Epub 2016 Aug 20.
2
TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.一名炎症性肠病患者出现肿瘤坏死因子α抑制剂诱发的狼疮样综合征(TAILS)。
Curr Health Sci J. 2014 Oct-Dec;40(4):285-8. doi: 10.12865/CHSJ.40.04.11. Epub 2014 Dec 14.
3
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.自身免疫性肝炎与抗肿瘤坏死因子α治疗:单中心8例报告
阿达木单抗诱发的系统性红斑狼疮:一例病例报告及文献综述。
SAGE Open Med Case Rep. 2023 Aug 12;11:2050313X231193077. doi: 10.1177/2050313X231193077. eCollection 2023.
4
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases.关注抗肿瘤坏死因子 (TNF)-α 相关自身免疫性疾病。
Int J Mol Sci. 2023 May 3;24(9):8187. doi: 10.3390/ijms24098187.
5
Infliximab-Induced Lupus in a Patient With Psoriatic Arthritis Who Presented With Cardiac Tamponade: A Case Report.英夫利昔单抗诱发的狼疮累及一名患有银屑病关节炎且出现心脏压塞的患者:病例报告
Cureus. 2023 Mar 20;15(3):e36424. doi: 10.7759/cureus.36424. eCollection 2023 Mar.
6
Adalimumab-Induced Lupus Serositis: A Case Report and Review of the Literature.阿达木单抗诱发的狼疮性浆膜炎:一例病例报告及文献复习
Cureus. 2023 Feb 2;15(2):e34568. doi: 10.7759/cureus.34568. eCollection 2023 Feb.
7
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.生物抗 TNF-α 疗法的过去、现在及(可预见的)未来
J Clin Med. 2023 Feb 17;12(4):1630. doi: 10.3390/jcm12041630.
8
The Function and Therapeutic Implications of TNF Signaling in MDSCs.TNF 信号在 MDSCs 中的功能及治疗意义。
Biomolecules. 2022 Nov 3;12(11):1627. doi: 10.3390/biom12111627.
9
Altered B cell phenotype and CD27+ memory B cells are associated with clinical features and environmental exposure in Colombian systemic lupus erythematosus patients.哥伦比亚系统性红斑狼疮患者的B细胞表型改变及CD27⁺记忆B细胞与临床特征和环境暴露相关。
Front Med (Lausanne). 2022 Sep 6;9:950452. doi: 10.3389/fmed.2022.950452. eCollection 2022.
10
Biologic Therapies and Autoimmune Phenomena.生物疗法与自身免疫现象
Mediterr J Rheumatol. 2021 Jun 30;32(2):96-103. doi: 10.31138/mjr.32.2.96. eCollection 2021 Jun.
World J Gastroenterol. 2015 Jun 28;21(24):7584-8. doi: 10.3748/wjg.v21.i24.7584.
4
Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials.赛妥珠单抗(certolizumab pegol)治疗类风湿关节炎的安全性概况更新:来自临床试验的综合分析
Ann Rheum Dis. 2015 Jan;74(1):96-103. doi: 10.1136/annrheumdis-2013-203660. Epub 2013 Oct 3.
5
Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis.英夫利昔单抗治疗银屑病期间的肝炎和狼疮样综合征
Case Rep Dermatol. 2013 Aug 14;5(2):219-24. doi: 10.1159/000354593. eCollection 2013.
6
Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.英夫利昔单抗治疗银屑病继发的药物性狼疮和自身免疫性肝炎。
Australas J Dermatol. 2014 Feb;55(1):75-9. doi: 10.1111/ajd.12054. Epub 2013 May 8.
7
A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept.一名强直性脊柱炎患者发生了英夫利昔单抗诱导的狼疮,并接受了依那西普治疗。
Rheumatol Int. 2014 Mar;34(3):443-4. doi: 10.1007/s00296-012-2617-8. Epub 2012 Dec 22.
8
Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship?药物性自身免疫性肝炎与 TNF-α 拮抗剂:是否存在真正的关系?
Autoimmun Rev. 2013 Jan;12(3):337-9. doi: 10.1016/j.autrev.2012.03.010. Epub 2012 Jul 25.
9
Inflammatory bowel disease and lupus: a systematic review of the literature.炎症性肠病与狼疮:文献系统综述。
J Crohns Colitis. 2012 Aug;6(7):735-42. doi: 10.1016/j.crohns.2012.03.005. Epub 2012 Apr 14.
10
Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease.英夫利昔单抗治疗炎性肠病后发生的自身免疫性肝炎。
J Crohns Colitis. 2012 Jun;6(5):630-1. doi: 10.1016/j.crohns.2012.01.017. Epub 2012 Feb 9.